
Precious Lifesciences Private Limited
Provides research and development services, trades medicine and chemicals, and distributes healthcare products globally.
Provides research and development services, trades medicine and chemicals, and distributes healthcare products globally.
Precious Lifesciences Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 2012 and has a history of 12 years and 11 months. Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.44 M.
Rabi Panda, Biswajit Dash, and Nibedita Dash serve as directors at the Company.
Khorda, Odisha, India
+91-XXXXXXXXXX
-
U52310OR2012PTC015157
015157
Private Limited Indian Non-Government Company
27 Mar 2012
30 Sep 2023
31 Mar 2023
Unlisted
Roc Cuttack
Precious Lifesciences Private Limited offers a wide range of products and services, including Ayurvedic Medicine, Asthma Herbal Capsule & Tablet, Pharmaceutical Syrup, Health Supplement, Herbal Sexual Health Supplement, Ayurvedic Erectile Dysfunction Capsules, Herbal Oil, Herbal Medicinal Oil, Ayurvedic Fever Tablet, Antihistamines.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rabi Panda ![]() | Managing Director | 27-Mar-2012 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Biswajit Dash ![]() | Director | 27-Mar-2012 | Current |
Nibedita Dash ![]() | Director | 01-Nov-2017 | Current |
Precious Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.7% increase. The company also saw a substantial improvement in profitability, with a 52.09% increase in profit. The company's net worth Soared by an impressive increase of 13.27%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Precious Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹6.44 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
31 Mar 2022 | Indian Bank | ₹1.44 M | Open |
05 Feb 2016 | Allahabad Bank | ₹5.00 M | Open |
Unlock and access historical data on people associated with Precious Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Precious Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Precious Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Precious Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Precious Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
A charge with Indian Bank amounted to Rs. 1.44 M with Charge ID 100586775 was registered on 31 Mar 2022.
Nibedita Dash was appointed as a Director was appointed as a Director on 01 Nov 2017 & has been associated with this company since 7 years 4 months .
A charge with Allahabad Bank amounted to Rs. 5.00 M with Charge ID 10622138 was registered on 05 Feb 2016.
Rabi Chandra Panda was appointed as a Managing Director was appointed as a Managing Director on 27 Mar 2012 & has been associated with this company since 12 years 11 months .
Precious Lifesciences Private Limited was incorporated on 27 Mar 2012.
The authorized share capital of Precious Lifesciences Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 3 directors are associated with Precious Lifesciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Precious Lifesciences Private Limited is B-203 Krishna Towers, Nayapalli India, Bhubaneswar, Orissa, 751012.
The corporate identification number (CIN) of Precious Lifesciences Private Limited is U52310OR2012PTC015157 and the company number is 015157 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Precious Lifesciences Private Limited has risen by 15.70%.
The financial reports for the fiscal year 2023 indicates that The net worth of Precious Lifesciences Private Limited has experienced an upsurge of 13.27%.
As per the financial statements for fiscal Year 2023, The total open charges for Precious Lifesciences Private Limited amount to ₹ 6.44 M.
The most recent Balance Sheet for Precious Lifesciences Private Limited was filed with the ROC on 31 Mar 2023.
PP